In a new study by the Yale Department of Immunobiology and Yale Cancer Center, researchers report combined liver and growth factor humanization enhances human red blood cell production and survival in circulation the immunodeficient murine host.
Article Correctness Is Author's Responsibility: Yale Researchers Identify Tumor Reactive Immune-Cells to help fight against Advanced Melanoma
According to a new study led by Yale Cancer Center and Department of Neurology researchers, a simple blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma, a deadly form of skin cancer. The …
Article Correctness Is Author's Responsibility: Study Shows New Treatment Pathway to Prevent and Treat Endometrial Cancer Recurrence
In a new study led by Yale Cancer Center, researchers demonstrate sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer.
Article Correctness Is Author's Responsibility: Maryam Lustberg Named Director of The ****** Center at Smilow Cancer Hospital and Chief of ****** Medical Oncology at Yale Cancer Center
Maryam Lustberg, MD, MPH, has been appointed Director of The ****** Center at Smilow Cancer Hospital and Chief of ****** Medical Oncology at Yale Cancer Center. She will also join the faculty at Yale Cancer Center as an Associate Professor of Medicine …
Article Correctness Is Author's Responsibility: Yale Cancer Center Study Shows Targeted Therapy Improves Survival for Advanced Bladder Cancer
In a new study led by researchers at Yale Cancer Center, the drug enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma or bladder cancer, who had…
Article Correctness Is Author's Responsibility: Researchers Discover Mechanism to Overcome Drug-Resistance in B-Cell Acute Lymphoblastic Leukemia
In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia. This mechanism depends on a molecule called PON2, which could lead to a new treatment for the disease. The findings were publishe…
Article Correctness Is Author's Responsibility: Dr. Rachel Greenup Appointed Chief of ****** Surgical Oncology at Yale
Rachel Adams Greenup, MD, MPH, FACS, has been appointed as Associate Professor of Surgery (Oncology) and Section Chief of ****** Surgery for the Department of Surgery at Yale School of Medicine. In her new role, Dr. Greenup will provide ****** surgical…
Article Correctness Is Author's Responsibility: Yale study leads to FDA approval of drug to treat non-small cell lung cancer
Based on results of a clinical trial led by Yale Cancer Center researchers, the U.S. Food and Drug Administration has approved osimertinib for the treatment of adults with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations, which …
Article Correctness Is Author's Responsibility: Roy S. Herbst, MD, PhD, Receives 2020 ACCC Clinical Research Award
Roy S. Herbst, MD, PhD, Chief of Medical Oncology and Associate Cancer Center Director for Translational Research at Yale Cancer Center and Smilow Cancer Hospital, has been selected as the 2020 Clinical Research Award recipient by the Association of Co…
Article Correctness Is Author's Responsibility: Dr. Stephanie Halene Appointed Chief of Hematology at Yale Cancer Center and Smilow Cancer Hospital
Following an extensive national search, Stephanie Halene, MD, PhD, has been appointed Chief of Hematology at Yale Cancer Center, Smilow Cancer Hospital and the Yale School of Medicine Department of Internal Medicine.
